Pfizer possesses several qualities that make it attractive when market volatility is high. The stock has a low forward earnings multiple and a higher -- yet still attractive -- EV-to-EBITDA ratio.
Lululemon’s valuation has compressed to levels investors rarely see. The company’s underlying strengths remain intact. The value case hinges on execution, not optimism. 10 stocks we like better than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback